US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist
  • 0.9065
  • +0.0011+0.12%
Close Aug 2 16:00 ET
  • 0.9100
  • +0.0035+0.39%
Post 19:21 ET
163.78MMarket Cap-3941P/E (TTM)

Citius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Citius Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.05

+28.57%
Analyst Rating

Strong Buy

Jul 31, 2024

Citius Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Citius Pharmaceuticals Earnings Reports

  • 10-Q: Quarterly report

    May 14 16:43 ET

  • Citius Pharmaceuticals | 10-Q: Quarterly report

    Feb 14 16:47 ET

  • Citius Pharmaceuticals: FY2023 Annual Report

    Dec 29, 2023 00:00 ET

  • Citius Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Aug 14, 2023 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg